Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.

Seventy-four post menopausal patients with primary non-metastatic invasive ductal carcinomas of the breast were first treated with tamoxifen alone (30 mg p.o. daily) for 5 months. To study changes induced by tamoxifen, core biopsies before treatment and surgical specimens after hormonal therapy were...

Descripción completa

Detalles Bibliográficos
Autores principales: Soubeyran, I., Quénel, N., Mauriac, L., Durand, M., Bonichon, F., Coindre J-M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074365/
https://www.ncbi.nlm.nih.gov/pubmed/8611373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074365/
https://www.ncbi.nlm.nih.gov/pubmed/8611373

Ejemplares similares